APA (7th ed.) Citation

D, Z., Z, Z., J, M., M, S., & C, C. (2025). Investigating subregional PD-L1 expression within primary tumors to predict clinical outcomes in advanced NSCLC patients who received ICB-based therapy. Frontiers in oncology, 15, 1497279. https://doi.org/10.3389/fonc.2025.1497279

Chicago Style (17th ed.) Citation

D, Zhou, Zhu Z, Mao J, Su M, and Chen C. "Investigating Subregional PD-L1 Expression Within Primary Tumors to Predict Clinical Outcomes in Advanced NSCLC Patients Who Received ICB-based Therapy." Frontiers in Oncology 15 (2025): 1497279. https://doi.org/10.3389/fonc.2025.1497279.

MLA (9th ed.) Citation

D, Zhou, et al. "Investigating Subregional PD-L1 Expression Within Primary Tumors to Predict Clinical Outcomes in Advanced NSCLC Patients Who Received ICB-based Therapy." Frontiers in Oncology, vol. 15, 2025, p. 1497279, https://doi.org/10.3389/fonc.2025.1497279.